Biliary tract infections treated with ciprofloxacin

Infection

Volumn 21, Issue 4, 1993, Pages 262-264

  Karachalios, G N ^a   Zografos, G ^a   Patrikakos, V ^a   Nassopoulou, D ^a   Kehagioglou, K ^a  

^a RED CROSS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANOREXIA; ARTICLE; BILIARY TRACT INFECTION; CHOLANGITIS; CHOLECYSTITIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHLEBITIS; PRIORITY JOURNAL; RASH;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; CHOLANGITIS; CHOLECYSTITIS; CIPROFLOXACIN; FEMALE; HUMAN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE; RECURRENCE; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0027282606     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/BF01728909     Document Type: Article

References (8)

1. Pharmacokinetics of ciprofloxacin: Intravenous and increasing oral dosing
2. The new quinolones: pharmacokinetic properties and clinical use of fluoroquinolones
3. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
4. Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamycin therapy for patients with cholangitis
5. Broad spectrum penicillin as an adequate therapy for acute cholangitis
6. Aminoglycosides: Assessing the potential for nephrotoxicity
7. Antibiotics in infection of the biliary tract
8. Use of ciprofloxacin in biliary sepsis